Minimization of steroids in kidney transplantation
Open Access
- 8 December 2008
- journal article
- review article
- Published by Frontiers Media SA in Transplant International
- Vol. 22 (1), 38-48
- https://doi.org/10.1111/j.1432-2277.2008.00728.x
Abstract
The goal of steroid minimization trials has been to minimize or eliminate steroid‐related side‐effects while simultaneously not increasing the rate of acute rejection (AR) and chronic graft loss. Early trials of late steroid withdrawal (≥3 months post‐transplant) were associated with significantly increased AR rates and late graft loss. More recent trials of rapid discontinuation of prednisone (RDP) (≤7 days post‐transplant) have been associated with little or no increase in AR rates and no difference in graft survival (versus maintenance prednisone). Of note, induction therapy appears to be important for success; however, it is not clear if any single maintenance protocol is superior. Intermediate‐term follow‐up (5–7 years) is now available for some randomized and nonrandomized trials; graft survival and renal function remain excellent. Most of these trials have been done in low immunologic risk recipients, but there are reports of success of RDP in children, black recipients, sensitized recipients, recipients with potentially recurring disease, and kidney–pancreas recipients. Of critical importance, steroid‐related side‐effects have been minimized. Steroid minimization protocols can clearly be recommended for low‐risk patients; additional trials are necessary for those at higher risk. Additional research is also necessary on integrating calcineurin inhibitor minimization with steroid minimization.Keywords
This publication has 85 references indexed in Scilit:
- A Randomized, Multicenter Study of Steroid Avoidance, Early Steroid Withdrawal or Standard Steroid Therapy in Kidney Transplant RecipientsAmerican Journal of Transplantation, 2008
- Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppressionClinical Transplantation, 2006
- Alemtuzumab Induction and Prednisone-Free Maintenance Immunotherapy in Simultaneous Pancreas-Kidney Transplantation Comparison With Rabbit Antithymocyte Globulin Induction – Long-Term ResultsAmerican Journal of Transplantation, 2006
- African-American Renal Transplant Recipients Benefit from Early Corticosteroid Withdrawal Under Modern ImmunosuppressionAmerican Journal of Transplantation, 2005
- A Multicenter Pilot Study of Early (4-Day) Steroid Cessation in Renal Transplant Recipients Under Simulect, Tacrolimus and SirolimusAmerican Journal of Transplantation, 2005
- Long-term Immunosuppression, Without Maintenance Prednisone, After Kidney TransplantationAnnals of Surgery, 2004
- Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation1Transplantation, 2003
- Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot studyTransplantation, 2002
- The natural history of azathioprine compliance after renal transplantationKidney International, 2001
- DOUBLE-BLIND COMPARISON OF TWO CORTICOSTEROID REGIMENS PLUS MYCOPHENOLATE MOFETIL AND CYCLOSPORINE FOR PREVENTION OF ACUTE RENAL ALLOGRAFT REJECTION1Transplantation, 2000